GLP-1 Treatments May Reduce Knee Replacement Surgery Rates

Pharmalittle: We're reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more

Eli Lilly has tapped into Ascidian Therapeutics' RNA-editing capabilities with a $1.9 billion collaboration focused on kidney diseases.

GLP-1 treatments may reduce knee replacement surgery rates

GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly lower long term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open access journal Regional Anesthesia & Pain Medicine.

Weight loss drugs may significantly reduce need for knee replacement surgery

New research has discovered a potential link between weight loss drugs and knee replacement surgery

GLP-1 agonists linked to significantly lower long-term risk of knee replacement

GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open-access journal Regional Anesthesia & Pain Medicine.

GLP-1 Drugs Cut Need for Knee Replacement

(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records database indicated. Compared with otherwise similar OA patients not taking...

Wegovy and Zepbound Could Reduce the Risk of Needing Knee Replacement

For people with both obesity and knee osteoarthritis , taking a GLP-1 may lower the risk of needing a knee replacement down the road, a new study found.e60dc2a1-f33c-4a05-9b50-8e3e8e597629dc362300-688e-4bb3-955d-e7a354cb85d7 “Looking at data from several thousands of patients, we found that those taking a GLP-1 were significantly less likely to end up needing a knee replacement, and the benefit grew the longer they took them,” says senior author…